Coming soon
Investor Centre AIM Rule 26
Last updated:
August 5, 2025
We are committed to transparency, good governance, and long-term value creation.
Our platform aggregates data across 100's of devices and apps (including Apple Health, Fitbit, Garmin, and Google Fit) to deliver real-time, personalized health insights.
We help users proactively manage well-being by detecting health patterns, providing actionable recommendations, and offering intelligent alerts – bridging the gap between raw data and practical guidance.
MedPal is a consumer-first, non-clinical digital health platform.
We do not offer medical advice or diagnostics. Instead, we empower users via a subscription-based app that uses AI to turn health data into preventive, personalized support.
1.
Registered Office:
Medpal AI LImited
8th Floor The Broadgate Tower
20 Primrose Street
London, EC2A 2EW
2.
Country of Incorporation and Main Operations:
The Company is registered in England and Wales with company number 13578804. Its main country of operation is the United Kingdom.
3.
Legal Status:
Public Limited Company (plc)
4.
Listing Information:
MedPal AI’s shares are admitted to trading on the AIM market of the London Stock Exchange under the ticker MPAL.
5.
Takeover Code:
The Company is subject to the UK City Code on Takeovers and Mergers.
Jason Drummond
(CEO)
Dr. Kevin O'Neill
(Independent Non-executive Director)
Karl Karlsson
(Non-executive Chairman)
Justin Piers Drummond
(Executive Director)
Adam Monaco
(Proposed Finance Director)
1.
Nominated Adviser:
Cairn Financial Advisers LLP
9th Floor 107 Cheapside
London EC2V 6DN
2.
Broker:
Clear Capital Markets Limited
6th Floor, Wilson’s Corner
23-23 Wilson Street
London EC2M 2DD
3.
Solicitors to the Company:
Hill Dickinson LLP
The Broadgate Tower
20 Primrose Street
London EC2A 2EW
4.
Auditors:
RPG Crouch Chapman LLP
40 Gracechurch Street
London EC4A 3BF
5.
Registrar:
Neville Registrars Limited
Neville House
Steelpark Road
Halesowen
West Midlands B62 8HD
